FDA — authorised 27 November 1974
- Marketing authorisation holder: RANBAXY
- Status: approved
FDA authorised Halog on 27 November 1974
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 27 November 1974; FDA authorised it on 4 May 1977; FDA authorised it on 15 June 1977.
RANBAXY holds the US marketing authorisation.